Exploring lung cancer genetics in patients of African ancestry
Understanding lung cancer genomics in patients of African ancestry
This study is looking into the genetic differences in lung cancer for people of African ancestry to find out why they often don't get the same advanced treatments as white patients, with the hope of improving care and outcomes for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10981834 on NIH RePORTER |
What this research studies
This research investigates the unique genetic factors associated with lung cancer in individuals of African ancestry. It aims to understand why these patients are less likely to receive advanced genomic testing and targeted therapies compared to their white counterparts. By analyzing real-world data, the study will identify specific genetic alterations and their frequencies in lung cancer among African American patients. The goal is to uncover disparities in treatment and improve outcomes for this population by tailoring therapies based on their genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals diagnosed with lung cancer.
Not a fit: Patients of non-African ancestry may not benefit directly from the findings of this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for lung cancer patients of African ancestry.
How similar studies have performed: Previous research has shown that understanding genetic differences in cancer can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Zhang, Jian — Sloan-Kettering Inst Can Research
- Study coordinator: Zhang, Jian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.